|
NDST1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.097800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84117999999511E-05 |
| Normal-vs-Stage2 |
7.346800E-01 |
| Normal-vs-Stage3 |
7.754200E-01 |
| Normal-vs-Stage4 |
7.197200E-01 |
| Stage1-vs-Stage2 |
4.122900E-03 |
| Stage1-vs-Stage3 |
1.166020E-04 |
| Stage1-vs-Stage4 |
8.19790000000653E-05 |
| Stage2-vs-Stage3 |
9.084000E-01 |
| Stage2-vs-Stage4 |
5.572000E-01 |
| Stage3-vs-Stage4 |
5.543200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.146430E-02 |
| Normal-vs-AfricanAmerican |
8.701900E-02 |
| Normal-vs-Asian |
8.422000E-01 |
| Caucasian-vs-AfricanAmerican |
5.655800E-01 |
| Caucasian-vs-Asian |
4.731000E-01 |
| AfricanAmerican-vs-Asian |
4.348400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.364100E-02 |
| Normal-vs-Female |
7.938300E-03 |
| Male-vs-Female |
3.090800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.626760E-01 |
| Normal-vs-Age(41-60Yrs) |
2.797800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.261230E-01 |
| Normal-vs-Age(81-100Yrs) |
5.868400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.123800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.424800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.449800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.493700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.882400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.728800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.742130E-02 |
| Normal-vs-Grade 2 |
2.364800E-04 |
| Normal-vs-Grade 3 |
2.094400E-01 |
| Normal-vs-Grade 4 |
1.843400E-01 |
| Grade 1-vs-Grade 2 |
7.390200E-02 |
| Grade 1-vs-Grade 3 |
2.759800E-02 |
| Grade 1-vs-Grade 4 |
1.000050E-02 |
| Grade 2-vs-Grade 3 |
8.181100E-03 |
| Grade 2-vs-Grade 4 |
3.1725000000371E-06 |
| Grade 3-vs-Grade 4 |
1.398170E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.186200E-04 |
| Normal-vs-ccB subtype |
2.440800E-01 |
| ccA subtype-vs-ccB subtype |
1.100170E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.981800E-02 |
| Normal-vs-N1 |
1.388240E-01 |
| N0-vs-N1 |
1.042790E-01 |
|
|
